Cirrhosis and Chronic Liver Disease
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Microplastics, Cirrhosis and Portal Hypertension
Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer
Evaluation of 'Melody' Paracentesis Device for Ascites Therapy
Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure
Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection